El Instituto Nacional de Defensa de la Competencia y de la Protección de la Propiedad Intelectual (Indecopi) sancionó a cinco cadenas de farmacias por concertar para fijar los precios de 36 medicamentos, atentando contra la competitividad y afectando de forma negativa a los consumidores en farmacias privadas.
Featured News
Saudi Arabia Reviews Uber’s $14.8 Billion Delivery Hero Takeover
Sep 24, 2026 by
CPI
Pope Leo Warns of AI Threats, Calls for Stronger Global Oversight
Sep 24, 2026 by
CPI
Paramount-Warner Bros. Discovery Merger Settlement Faces Coalition Challenge
Sep 24, 2026 by
CPI
New York Grocery Plan Puts Predatory-Pricing Rules to the Test
Sep 24, 2026 by
CPI
Nvidia CEO Opposes Antitrust, Liability Carveouts for AI Firms
Sep 24, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton